Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer

Overview of attention for article published in BMC Cancer, March 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 33 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 19 publications that cite this research output.

19

The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.

Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with BRCA mutated advanced high grade serous ovarian cancer: 10 year survival analysis

Article in International Journal of Gynecological Cancer (March 2024)

Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy

Article in Journal of Gynecologic Oncology (March 2024)

Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy

Article in JAMA Surgery (November 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.